NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
– Anticipates preliminary unaudited fourth quarter 2025 revenue of approximately $190 million; full-year 2025 revenue of $727 million – – Announces Chief Financial... Read more.
FIS Launches Industry-First Offering Enabling Banks to Lead and Scale in Agentic Commerce
First-of-its-kind capabilities will help FIS bank clients remain top of wallet with cardholders by enabling agentic commerce while enhancing fraud protection. FIS... Read more.
Independence Power Holdings, Inc. Completes Business Combination/Reverse Merger with TriUnity Business Services; Addresses Permian Basin Power Shortfall with Software-Driven Microgrids
MENTONE, Texas–(BUSINESS WIRE)–Independence Power Holdings, Inc. (OTC ticker: ITXP) (“Independence Power” or the “Company”) today announced its... Read more.
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy
Phase 1/2a ELIMINATE-B trial for PBGENE-HBV ongoing across multiple dosing cohorts; Data updates expected at medical conferences in 2026 PBGENE-DMD expecting IND... Read more.
Healthpeak Properties Announces $925 Million of Transaction Activity
DENVER–(BUSINESS WIRE)–Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and... Read more.
Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
SCOUT-HCM demonstrated the superiority of Camzyos on the primary endpoint and multiple secondary endpoints The overall safety results in this study were consistent... Read more.
Genesco Reports Comparable Sales
–Fourth Quarter-to-Date Comparable Sales Increased 9% Year-Over-Year– –Company Now Expects Increased Fiscal 2026 Adjusted EPS to be at Least $1.301—... Read more.
Study Shows NuScale Power Technology Can Support Profitable, Reliable Power for Chemical Plants
Study validates an exciting path for powering commercial chemical plants Findings show that pairing NuScale’s advanced nuclear technology with a heat augmentation... Read more.
US Foods Reaffirms Fiscal Year 2025 Guidance
Company to Participate at the 2026 ICR Conference ROSEMONT, Ill.–(BUSINESS WIRE)–US Foods Holding Corp. (NYSE: USFD) announced today that it is reaffirming... Read more.
J.Jill, Inc. Raises Fourth Quarter Guidance Ahead of the 28th Annual ICR Conference
QUINCY, Mass.–(BUSINESS WIRE)–J.Jill, Inc. (NYSE:JILL) today raised its fourth quarter fiscal 2025 guidance in advance of its fireside chat and investor... Read more.